FDA Approval Activities for this Drug…

Mobic (meloxicam) Tablets, 7.5 & 15 mg., Boehringer Ingleheim NDA 20-938/S7 4/28/03 Mobic (meloxicam) Tablets, 7.5 mg., Boehringer Ingleheim NDA 20-938 4/13/00 4/17/00 4/17/00 7/18/01 Mobic Indication: Relief of the signs and symptoms of Osteoarthritis. Mobic (meloxicam) Oral Suspension, Boehringer Ingelheim

For the latest approval information, please locate this drug using this index.